Answers are grounded in this paper and cite their sources.
Review discusses advancements in targeted drug delivery with nanoparticles, highlighting implications for therapeutics.
Targeted drug delivery has revolutionized modern therapeutics by the enabling site-specific drug action while minimizing systemic toxicity. Nanoparticles have emerged as the promising carriers due to their unique physicochemical properties, including small size, high surface area, tunable surface characteristics, and ability to encapsulate diverse therapeutic agents. Various nanoparticle systems such as polymeric nanoparticles, lipid nanoparticles, dendrimers, metallic nanoparticles, and mesoporous silica nanoparticles have the demonstrated significant potential in improving drug bioavailability, pharmacokinetics, and therapeutic outcomes. Recent advancements in nanotechnology have facilitated the development of smart and stimuli-responsive nanoparticles capable of targeted drug release in response to the specific physiological conditions. This review discusses the classification, mechanisms, recent advances, therapeutic applications, challenges, and future perspectives of nanoparticle-based targeted drug delivery systems.
No takes yet. Share an insight, caveat, or question.
*Mr. R. Sachithananthan, Miss. Narmatha S., S. Sivabharath, A. Dhanush, S. Salomiya (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: